Medical Care Unit Dachau

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Ulcerative colitis3 trials

Phase

• Phase 23 trials

Status

• Completed1 trial
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Spyre Therapeutics, Inc.2 trials
• Anaptysbio Inc.1 trial

Running trials

• Enrolling by invitation

  Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD

  NCT07652294· Phase 2· Spyre Therapeutics, Inc.· Source

• Recruiting

  A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  NCT07012395· Phase 2· Spyre Therapeutics, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Ulcerative colitis2 recruiting

Closed trials

• Completed

  Efficacy and Safety of Rosnilimab in Subjects with Ulcerative Colitis

  2023-508679-34-00· Phase 2· Anaptysbio Inc.· Source